Profile of Xeomin(®) (incobotulinumtoxinA) for the treatment of blepharospasm

Even though conventional botulinum neurotoxin (BoNT) products have shown successful treatment results in patients with benign blepharospasm (BEB), the main, potential long-term side effect of BoNT use is the development of immunologic resistance due to the production of neutralizing antibody to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Juwan, Lee, Michael S, Harrison, Andrew R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116796/
https://www.ncbi.nlm.nih.gov/pubmed/21691580
http://dx.doi.org/10.2147/OPTH.S13978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116796/
https://www.ncbi.nlm.nih.gov/pubmed/21691580
http://dx.doi.org/10.2147/OPTH.S13978

Ejemplares similares